Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03564782
Title Examining Bioactivity of PVSRIPO in Invasive Breast Cancer
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors Istari Oncology, Inc.
Indications

Her2-receptor positive breast cancer

triple-receptor negative breast cancer

Therapies

PVSRIPO

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.